Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Oct 22;287(6400):1169–1172. doi: 10.1136/bmj.287.6400.1169

Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.

W MacNee, C G Wathen, W J Hannan, D C Flenley, A L Muir
PMCID: PMC1549376  PMID: 6138118

Abstract

The acute haemodynamic effects of oral pirbuterol (a beta-agonist) were contrasted with those of sodium nitroprusside, a vasodilator, in six patients with hypoxic chronic bronchitis and emphysema. Sodium nitroprusside (1-5 mg/kg intravenously) reduced mean pulmonary arterial pressure and total pulmonary vascular resistance significantly (p less than 0.01) without change in cardiac output or right ventricular ejection fraction, measured by radionuclide ventriculography. Oral pirbuterol (22.5 mg) produced a greater reduction in total pulmonary vascular resistance than sodium nitroprusside, largely as a result of increasing cardiac output. Right ventricular ejection fraction also increased significantly after pirbuterol (p less than 0.01). Pirbuterol in a lower dosage (15 mg by mouth) in six further patients with hypoxic chronic bronchitis and emphysema produced similar changes in total pulmonary vascular resistance and right ventricular ejection fraction. Nine of the patients who were studied acutely thereafter received pirbuterol 15 mg thrice daily for six weeks, which produced a significant fall in systolic pulmonary arterial pressure and a rise in right ventricular ejection fraction (p less than 0.01), without a significant fall in arterial oxygen tension. Pirbuterol acts as a vasodilator on the pulmonary circulation in these patients and may in addition improve right ventricular performance by an inotropic action.

Full text

PDF
1169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awan N. A., Evenson M. K., Needham K. E., Evans T. O., Hermanovich J., Taylor C. R., Amsterdam E., Mason D. T. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure. Circulation. 1981 Jan;63(1):96–101. doi: 10.1161/01.cir.63.1.96. [DOI] [PubMed] [Google Scholar]
  2. Awan N. A., Needham K., Evenson M. K., Hermanovich J., Joye J. A., DeMaria A. N., Mason D. T. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation. Am Heart J. 1981 Sep;102(3 Pt 2):555–563. doi: 10.1016/0002-8703(81)90744-4. [DOI] [PubMed] [Google Scholar]
  3. Brent B. N., Mahler D., Berger H. J., Matthay R. A., Pytlik L., Zaret B. L. Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study. Am J Cardiol. 1982 Aug;50(2):313–319. doi: 10.1016/0002-9149(82)90182-5. [DOI] [PubMed] [Google Scholar]
  4. Burrows B., Kettel L. J., Niden A. H., Rabinowitz M., Diener C. F. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med. 1972 Apr 27;286(17):912–918. doi: 10.1056/NEJM197204272861703. [DOI] [PubMed] [Google Scholar]
  5. Colucci W. S., Alexander R. W., Mudge G. H., Rude R. E., Holman B. L., Wynne J., Grossman W., Braunwald E. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):564–568. doi: 10.1016/0002-8703(81)90745-6. [DOI] [PubMed] [Google Scholar]
  6. Dawson J. R., Canepa-Anson R., Kuan P., Whitaker N. H., Carnie J., Warnes C., Reuben S. R., Poole-Wilson P. A., Sutton G. C. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1423–1426. doi: 10.1136/bmj.282.6274.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Emirgil C., Sobol B. J., Herbert W. H., Trout K. W. Routine pulmonary function studiess a key to the status of the lesser circulation in chronic obstructive pulmonary disease. Am J Med. 1971 Feb;50(2):191–199. doi: 10.1016/0002-9343(71)90148-3. [DOI] [PubMed] [Google Scholar]
  8. FERRER M. I. DISTURBANCES IN THE CIRCULATION IN PATIENTS WITH COR PULMONALE. Bull N Y Acad Med. 1965 Sep;41:942–958. [PMC free article] [PubMed] [Google Scholar]
  9. Falkner F. C., McIlhenny H. M. Selected ion monitoring assay for the bronchodilator pirbuterol. Biomed Mass Spectrom. 1976 Oct;3(5):207–211. doi: 10.1002/bms.1200030503. [DOI] [PubMed] [Google Scholar]
  10. Gold F. L., Horwitz L. D. Hemodynamic effects of pirbuterol in conscious dogs. Am Heart J. 1981 Sep;102(3 Pt 2):591–596. doi: 10.1016/0002-8703(81)90749-3. [DOI] [PubMed] [Google Scholar]
  11. Jones R. M., Stockley R. A., Bishop J. M. Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension. Thorax. 1982 Oct;37(10):746–750. doi: 10.1136/thx.37.10.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGavin C. R., Gupta S. P., McHardy G. J. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J. 1976 Apr 3;1(6013):822–823. doi: 10.1136/bmj.1.6013.822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moore P. F., Constantine J. W., Barth W. E. Pirbuterol, a selecttve beta2 adrenergic bronchodilator. J Pharmacol Exp Ther. 1978 Nov;207(2):410–418. [PubMed] [Google Scholar]
  14. Nelson G. I., Silke B., Barker M. C., Saxton C. A., Taylor S. H. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure. Eur Heart J. 1982 Jun;3(3):238–245. doi: 10.1093/oxfordjournals.eurheartj.a061299. [DOI] [PubMed] [Google Scholar]
  15. Palmer K. N., Diament M. L. Effect of aerosol isoprenaline on blood-gas tensions in severe bronchial asthma. Lancet. 1967 Dec 9;2(7528):1232–1233. doi: 10.1016/s0140-6736(67)90567-3. [DOI] [PubMed] [Google Scholar]
  16. Rees H. A., Borthwick R. C., Millar J. S., Donald K. W. Aminophylline in bronchial asthma. Lancet. 1967 Dec 2;2(7527):1167–1169. doi: 10.1016/s0140-6736(67)91890-9. [DOI] [PubMed] [Google Scholar]
  17. Renzetti A. D., Jr, McClement J. H., Litt B. D. The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med. 1966 Jul;41(1):115–129. doi: 10.1016/0002-9343(66)90009-x. [DOI] [PubMed] [Google Scholar]
  18. Rude R. E., Turi Z., Brown E. J., Lorell B. H., Colucci W. S., Mudge G. H., Jr, Taylor C. R., Grossman W. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure. Circulation. 1981 Jul;64(1):139–145. doi: 10.1161/01.cir.64.1.139. [DOI] [PubMed] [Google Scholar]
  19. Sagawa K., Suga H., Shoukas A. A., Bakalar K. M. End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol. 1977 Nov;40(5):748–753. doi: 10.1016/0002-9149(77)90192-8. [DOI] [PubMed] [Google Scholar]
  20. Sharma B., Hoback J., Francis G. S., Hodges M., Asinger R. W., Cohn J. N., Taylor C. R. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure. Am Heart J. 1981 Sep;102(3 Pt 2):533–541. doi: 10.1016/0002-8703(81)90741-9. [DOI] [PubMed] [Google Scholar]
  21. Stockley R. A., Finnegan P., Bishop J. M. Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax. 1977 Oct;32(5):601–605. doi: 10.1136/thx.32.5.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Teule G. J., Majid P. A. Haemodynamic effects of terbutaline in chronic obstructive airways disease. Thorax. 1980 Jul;35(7):536–542. doi: 10.1136/thx.35.7.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weitzenblum E., Loiseau A., Hirth C., Mirhom R., Rasaholinjanahary J. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest. 1979 Jun;75(6):656–662. doi: 10.1378/chest.75.6.656. [DOI] [PubMed] [Google Scholar]
  24. Xue Q. F., MacNee W., Flenley D. C., Hannan W. J., Adie C. J., Muir A. L. Can right ventricular performance be assessed by equilibrium radionuclide ventriculography? Thorax. 1983 Jul;38(7):486–493. doi: 10.1136/thx.38.7.486. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES